55 Results for "

RIP-1

" in MedChemExpress (MCE) Product Catalog:
Products (55)

55 Results for "RIP-1" in MCE Product Catalog:

755
755 Publications Verification
Cat. No.: HY-16658B
CAS No.: 161401-82-7
Synonyms: Z-VAD(OH)-FMK
Z-VAD-FMK is a pan-caspase inhibitor and also an ICE-like protease inhibitor, which inhibits apoptosis by preventing the processing of CPP32 to its active form. Z-VAD-FMK sensitivity varies primarily due to differential expression of receptor-interacting protein 1 (RIP1). Z-VAD-FMK limits the cryopreservation-induced apoptosis by reducing caspase-3 activity of in vitro produced bovine embryos. Z-VAD-FMK is immunosuppressive in vitro and inhibits T cell proliferation without blocking the processing of caspase-8 and caspase-3. Z-VAD-FMK leads to a decrease in intracellular glutathione (GSH) with a concomitant increase in reactive oxygen species (ROS) levels in activated T cells. Z-VAD-FMK is due to oxidative stress via the depletion of GSH. Z-VAD-FMK can be used for the study of acute pancreatitis [1] .
514
514 Cited Publications
Cat. No.: HY-15760
CAS No.: 4311-88-0
Purity:  99.89%
Synonyms: Nec-1
Necrostatin-1 (Nec-1) is a potent and cross the blood-brain barrier necroptosis inhibitor with an EC50 of 490 nM in Jurkat cells. Necrostatin-1 inhibits RIP1 kinase (EC50=182 nM). Necrostatin-1 is also an IDO inhibitor [1].
8
8 Cited Publications
Cat. No.: HY-101760
CAS No.: 1622848-92-3
Purity:  99.79%
GSK2982772 is a potent, orally active and ATP competitive RIP1 kinase inhibitor with IC50 values of 16 nM and 20 nM for human and monkey RIP1, respectively [1].
8
8 Cited Publications
Cat. No.: HY-101032
CAS No.: 1956370-21-0
Purity:  99.94%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with an IC50 of 13 nM. RIPA-56 can be used for the treatment of systemic inflammatory response syndrome [1].
7
7 Cited Publications
Cat. No.: HY-144828
CAS No.: 2682850-41-3
Purity:  ≥97.0%
Research Areas:  

Cancer

RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability [1].
2
2 Cited Publications
Cat. No.: HY-N2166
CAS No.: 17406-45-0
Synonyms: α-Tomatine; Lycopersicin; Tomatin
Tomatine is a glycoalkaloid, found in the tomato plant (Lycopersicon esculentum Mill.). Tomatine elicits neurotoxicity in RIP1 kinase and caspase-independent manner. Tomatine promotes the upregulation of nuclear apoptosis inducing factor (AIF) in neuroblastoma cells. Tomatine also inhibits 20S proteasome activity [1].
2
2 Cited Publications
Cat. No.: HY-122909
CAS No.: 1337531-06-2
Purity:  99.07%
Synonyms: GSK'074
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK2593074A (GSK’074) is a necroptosis inhibitor with dual targeting ability to both RIP1 and RIP3 [1].
1
1 Cited Publications
Cat. No.: HY-103028A
CAS No.: 2049868-46-2
Purity:  99.10%
Target:  

RIP kinase

Research Areas:  

Others

GSK963 is a chiral, highly potent and selective inhibitor of RIP1 kinase, with an IC50 of 29 nM. GSK963 is a selective and potent inhibitor of necroptosis in murine and human cells in vitro [1].
1
1 Cited Publications
Cat. No.: HY-111946
CAS No.: 1622849-43-7
Purity:  99.39%
Target:  

RIP kinase

Research Areas:  

Cancer

GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM [1].
1
1 Cited Publications
Cat. No.: HY-100131
CAS No.: 1622849-58-4
Purity:  98.57%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK481 is a highly potent, selective, and specific receptor interacting protein 1 (RIP1) kinase inhibitor with an IC50 of 1.3 nM, which inhibits Ser 166 phosphorylation in wild-type human RIP1 (IC50=2.8 nM). GSK481 also exhibits excellent translation in the U937 cellular assay with an IC50 of 10 nM [1].
1
1 Cited Publications
Cat. No.: HY-124546
CAS No.: 337349-54-9
Purity:  99.40%
Synonyms: Nec-5
Target:  

Necroptosis RIP kinase

Research Areas:  

Neurological Disease

Necrostatin-5 (Nec-5) is a potent necroptosis inhibitor with an EC50 value of 0.24 µM. Necrostatin-5 also is a RIP1 inhibitor. Necrostatin-5 shows cardioprotective effects [1] .
Cat. No.: HY-152846
CAS No.: 2268739-68-8
Synonyms: GDC-8264
Flizasertib (GDC-8264) is an orally active, reversible and selective RIP1 inhibitor with Ki app values of 0.00071 μM and 0.0013 μM for human and cynomolgus monkey RIP1 kinase, respectively. Flizasertib blocks RIP1 autophosphorylation but does not affect RIP1 protein stability. Flizasertib inhibits pro-inflammatory cytokines (CCL3, CCL4, and IL-1β) production. Flizasertib results in inhibition of colitis and ileitis. Flizasertib can be used in the research of cardiac surgery-associated acute kidney injury [1] .
Cat. No.: HY-111409
CAS No.: 2095515-38-9
Purity:  99.96%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIP1 kinase inhibitor 1 (compound 22) is a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor (pKi=9.04) [1].
Cat. No.: HY-128585
CAS No.: 2438637-64-8
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology Cancer

GNE684 is a potent inhibitor of potent receptor interacting protein 1 (RIP1), with mean Ki app values of 21 nM, 189 nM and 691 nM for human mouse and rat RIP1, respectively [1].
Cat. No.: HY-18901
CAS No.: 1481641-08-0
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIPK1-IN-4 (compound 8) is a potent and selective type II kinase inhibitor of receptor interacting protein 1 (RIP1) kinase and binds to a DLG-out inactive form of RIP1 with an IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase [1].
Cat. No.: HY-173185
Target:  

RIP kinase Necroptosis

Research Areas:  

Inflammation/Immunology

RIP1-IN-1 is an orally active RIP1 inhibitor with strong RIP1 binding affinity (Kd: 110 nM). RIP1-IN-1 exhibits strong anti-necroptosis activity. RIP1-IN-1 effectively inhibits the formation of necrosomes by blocking the phosphorylation of RIP1, RIP3 and MLKL signaling pathways. RIP1-IN-1 inhibits necroptosis and can be used in the study of acute liver injury [1].
Cat. No.: HY-RS11992
Research Areas:  

Others

RIPK1 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS11993
Research Areas:  

Others

Ripk1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ripk1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-153435
CAS No.: 2428422-17-5
Target:  

RIP kinase Necroptosis

Research Areas:  

Cancer

RIP1 kinase inhibitor 5 (example 1) is a potent inhibitor of RIP1, which is used as a checkpoint kinase to control tumor immunity [1]. RIP1 kinase inhibitor 5 is similar with SIR1-365 (compound 13), which inhibits necrosis and iron death activity .
Cat. No.: HY-18899
CAS No.: 1504558-72-8
Target:  

RIP kinase

Research Areas:  

Cancer

Nec-3a is a Necrostatin-3 analogue. Nec-3a is a RIP1 inhibitor (IC50: 0.44 μM). Nec-3a inhibits the autophosphorylation activity of the RIP1 kinase domain [1].